440 Investment Group LLC boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 39.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,454 shares of the healthcare conglomerate’s stock after acquiring an additional 10,254 shares during the period. UnitedHealth Group accounts for approximately 5.7% of 440 Investment Group LLC’s portfolio, making the stock its 2nd largest holding. 440 Investment Group LLC’s holdings in UnitedHealth Group were worth $8,037,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Capital International Investors grew its holdings in UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after buying an additional 3,304,902 shares in the last quarter. Jennison Associates LLC grew its holdings in UnitedHealth Group by 146.0% during the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after buying an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC grew its holdings in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after buying an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC grew its holdings in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after buying an additional 1,562,661 shares in the last quarter. Institutional investors and hedge funds own 86.00% of the company’s stock.
A number of research firms have weighed in on UNH. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a report on Saturday, January 20th. Argus lifted their target price on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a report on Thursday, January 18th. Deutsche Bank lifted their target price on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Citigroup lifted their target price on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $259.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $243.22.
Shares of UnitedHealth Group Inc (NYSE UNH) opened at $229.37 on Monday. The stock has a market capitalization of $222,270.00, a P/E ratio of 24.14, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group Inc has a 52 week low of $156.49 and a 52 week high of $250.79.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.11 earnings per share. equities analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.31%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,396 shares of company stock valued at $12,262,067. 0.89% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This article was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.thelincolnianonline.com/2018/02/19/unitedhealth-group-inc-unh-shares-bought-by-440-investment-group-llc.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.